Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.

Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG.

Eur J Nucl Med Mol Imaging. 2019 Aug 10. doi: 10.1007/s00259-019-04434-0. [Epub ahead of print]

PMID:
31399803
2.

Enhancing CAR T-cell therapy through cellular imaging and radiotherapy.

Minn I, Rowe SP, Pomper MG.

Lancet Oncol. 2019 Aug;20(8):e443-e451. doi: 10.1016/S1470-2045(19)30461-9. Epub 2019 Jul 29. Review.

PMID:
31364596
3.

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.

Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG.

Sci Adv. 2019 Jul 3;5(7):eaaw5096. doi: 10.1126/sciadv.aaw5096. eCollection 2019 Jul.

4.

Preclinical evaluation of 203/212Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer.

Ray Banerjee S, Minn IL, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess A, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG.

J Nucl Med. 2019 Jun 28. pii: jnumed.119.229393. doi: 10.2967/jnumed.119.229393. [Epub ahead of print]

PMID:
31253744
5.

Design and synthesis of dye-conjugated hepsin inhibitors.

Kim K, Kwon H, Choi D, Lim T, Minn I, Son SH, Byun Y.

Bioorg Chem. 2019 Aug;89:102990. doi: 10.1016/j.bioorg.2019.102990. Epub 2019 May 20.

PMID:
31136899
6.

PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).

Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper MG.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1686-1691. doi: 10.1073/pnas.1812155116. Epub 2019 Jan 11.

7.

Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors.

Vaidyanathan G, Kang CM, McDougald D, Minn I, Brummet M, Pomper MG, Zalutsky MR.

Nucl Med Biol. 2018 Jul - Aug;62-63:18-30. doi: 10.1016/j.nucmedbio.2018.05.002. Epub 2018 May 5.

8.

Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation.

Foss CA, Plyku D, Ordonez AA, Sanchez-Bautista J, Rosenthal HB, Minn I, Lodge MA, Pomper MG, Sgouros G, Jain SK.

J Nucl Med. 2018 Nov;59(11):1751-1756. doi: 10.2967/jnumed.117.207431. Epub 2018 Apr 26.

9.

Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo.

Zhang HK, Chen Y, Kang J, Lisok A, Minn I, Pomper MG, Boctor EM.

J Biophotonics. 2018 Sep;11(9):e201800021. doi: 10.1002/jbio.201800021. Epub 2018 Jun 28.

10.

Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer.

Banerjee SR, Song X, Yang X, Minn I, Lisok A, Chen Y, Bui A, Chatterjee S, Chen J, van Zijl PCM, McMahon MT, Pomper MG.

Chemistry. 2018 May 17;24(28):7235-7242. doi: 10.1002/chem.201800882. Epub 2018 Apr 26.

11.

18F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine Receptor.

Coughlin JM, Slania S, Du Y, Rosenthal HB, Lesniak WG, Minn I, Smith GS, Dannals RF, Kuwabara H, Wong DF, Wang Y, Horti AG, Pomper MG.

J Nucl Med. 2018 Oct;59(10):1603-1608. doi: 10.2967/jnumed.117.205492. Epub 2018 Mar 1.

12.

The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F]ASEM.

Coughlin JM, Du Y, Rosenthal HB, Slania S, Min Koo S, Park A, Solomon G, Vranesic M, Antonsdottir I, Speck CL, Rootes-Murdy K, Lerner A, Rowe SP, Wang Y, Lesniak WG, Minn I, Bakker A, Smith GS, Dannals RF, Kuwabara H, Horti A, Wong DF, Pomper MG.

Neuroimage. 2018 Jan 15;165:118-124. doi: 10.1016/j.neuroimage.2017.10.009. Epub 2017 Oct 7.

13.

A PSMA-targeted theranostic agent for photodynamic therapy.

Chen Y, Chatterjee S, Lisok A, Minn I, Pullambhatla M, Wharram B, Wang Y, Jin J, Bhujwalla ZM, Nimmagadda S, Mease RC, Pomper MG.

J Photochem Photobiol B. 2017 Feb;167:111-116. doi: 10.1016/j.jphotobiol.2016.12.018. Epub 2016 Dec 18.

14.

Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players.

Coughlin JM, Wang Y, Minn I, Bienko N, Ambinder EB, Xu X, Peters ME, Dougherty JW, Vranesic M, Koo SM, Ahn HH, Lee M, Cottrell C, Sair HI, Sawa A, Munro CA, Nowinski CJ, Dannals RF, Lyketsos CG, Kassiou M, Smith G, Caffo B, Mori S, Guilarte TR, Pomper MG.

JAMA Neurol. 2017 Jan 1;74(1):67-74. doi: 10.1001/jamaneurol.2016.3764.

15.

18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase.

Horti AG, Wang Y, Minn I, Lan X, Wang J, Koehler RC, Alkayed NJ, Dannals RF, Pomper MG.

J Nucl Med. 2016 Nov;57(11):1817-1822. Epub 2016 Jul 14.

16.

Detecting Tumor Metastases: The Road to Therapy Starts Here.

Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB.

Adv Cancer Res. 2016;132:1-44. doi: 10.1016/bs.acr.2016.07.001. Epub 2016 Aug 17. Review.

17.

Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation.

He QL, Minn I, Wang Q, Xu P, Head SA, Datan E, Yu B, Pomper MG, Liu JO.

Angew Chem Int Ed Engl. 2016 Sep 19;55(39):12035-9. doi: 10.1002/anie.201606121. Epub 2016 Aug 30.

PMID:
27574181
18.

[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma.

Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA, Sysa-Shah P, Lewis WD, Ahn HH, Wang Y, Banerjee SR, Mease RC, Nimmagadda S, Allaf ME, Pomper MG, Yang X.

Oncotarget. 2016 Aug 30;7(35):56471-56479. doi: 10.18632/oncotarget.10602.

19.
20.

(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.

Kiess AP, Minn I, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel MW, Mease RC, Sgouros G, Zalutsky MR, Pomper MG.

J Nucl Med. 2016 Oct;57(10):1569-1575. Epub 2016 May 26.

21.

Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.

Subedi M, Minn I, Chen J, Kim Y, Ok K, Jung YW, Pomper MG, Byun Y.

Eur J Med Chem. 2016 Aug 8;118:208-218. doi: 10.1016/j.ejmech.2016.04.033. Epub 2016 Apr 14.

22.

Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery.

Williford JM, Archang MM, Minn I, Ren Y, Wo M, Vandermark J, Fisher PB, Pomper MG, Mao HQ.

ACS Biomater Sci Eng. 2016 Apr 11;2(4):567-578. Epub 2016 Mar 3.

23.

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma.

Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, Kim PK, Ford CN, Higgs C, Hayes LN, Schretlen DJ, Dannals RF, Kassiou M, Sawa A, Pomper MG.

Transl Psychiatry. 2016 Apr 12;6:e777. doi: 10.1038/tp.2016.40.

24.

Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.

Yang X, Minn I, Rowe SP, Banerjee SR, Gorin MA, Brummet M, Lee HS, Koo SM, Sysa-Shah P, Mease RC, Nimmagadda S, Allaf ME, Pomper MG.

Oncotarget. 2015 Oct 20;6(32):33733-42. doi: 10.18632/oncotarget.5254.

25.

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.

Kiess AP, Minn I, Chen Y, Hobbs R, Sgouros G, Mease RC, Pullambhatla M, Shen CJ, Foss CA, Pomper MG.

J Nucl Med. 2015 Sep;56(9):1401-1407. doi: 10.2967/jnumed.115.155929. Epub 2015 Jul 16.

26.

Tumor-specific expression and detection of a CEST reporter gene.

Minn I, Bar-Shir A, Yarlagadda K, Bulte JW, Fisher PB, Wang H, Gilad AA, Pomper MG.

Magn Reson Med. 2015 Aug;74(2):544-9. doi: 10.1002/mrm.25748. Epub 2015 Apr 27.

27.

Tuning phenols with Intra-Molecular bond Shifted HYdrogens (IM-SHY) as diaCEST MRI contrast agents.

Yang X, Yadav NN, Song X, Ray Banerjee S, Edelman H, Minn I, van Zijl PC, Pomper MG, McMahon MT.

Chemistry. 2014 Nov 24;20(48):15824-32. doi: 10.1002/chem.201403943. Epub 2014 Oct 10.

28.

Molecular-genetic imaging of cancer.

Minn I, Menezes ME, Sarkar S, Yarlagadda K, Das SK, Emdad L, Sarkar D, Fisher PB, Pomper MG.

Adv Cancer Res. 2014;124:131-69. doi: 10.1016/B978-0-12-411638-2.00004-5. Review.

29.

AEG-1 promoter-mediated imaging of prostate cancer.

Bhatnagar A, Wang Y, Mease RC, Gabrielson M, Sysa P, Minn I, Green G, Simmons B, Gabrielson K, Sarkar S, Fisher PB, Pomper MG.

Cancer Res. 2014 Oct 15;74(20):5772-81. doi: 10.1158/0008-5472.CAN-14-0018. Epub 2014 Aug 21.

30.

A red-shifted fluorescent substrate for aldehyde dehydrogenase.

Minn I, Wang H, Mease RC, Byun Y, Yang X, Wang J, Leach SD, Pomper MG.

Nat Commun. 2014 Apr 23;5:3662. doi: 10.1038/ncomms4662.

31.

Heterobivalent agents targeting PSMA and integrin-αvβ3.

Shallal HM, Minn I, Banerjee SR, Lisok A, Mease RC, Pomper MG.

Bioconjug Chem. 2014 Feb 19;25(2):393-405. doi: 10.1021/bc4005377. Epub 2014 Jan 22.

32.

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.

Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, Feller-Kopman D, Yarmus LB, Lin YC, Welm AL, Issa JP, Minn I, Matsui W, Jang YY, Sharkis SJ, Baylin SB, Zahnow CA.

Cancer Cell. 2012 Mar 20;21(3):430-46. doi: 10.1016/j.ccr.2011.12.029.

33.

p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma.

Roh JL, Kang SK, Minn I, Califano JA, Sidransky D, Koch WM.

Oral Oncol. 2011 Jan;47(1):8-15. doi: 10.1016/j.oraloncology.2010.10.011. Epub 2010 Dec 15.

34.

SUN-1 and ZYG-12, mediators of centrosome-nucleus attachment, are a functional SUN/KASH pair in Caenorhabditis elegans.

Minn IL, Rolls MM, Hanna-Rose W, Malone CJ.

Mol Biol Cell. 2009 Nov;20(21):4586-95. doi: 10.1091/mbc.E08-10-1034. Epub 2009 Sep 16.

35.

Cell type-specific and sexually dimorphic expression of transcription factor AP-2 in the adult mouse brain.

Coelho DJ, Sims DJ, Ruegg PJ, Minn I, Muench AR, Mitchell PJ.

Neuroscience. 2005;134(3):907-19.

PMID:
16009501
36.

Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I.

Kim HS, Yoon H, Minn I, Park CB, Lee WT, Zasloff M, Kim SC.

J Immunol. 2000 Sep 15;165(6):3268-74.

37.

Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.

Minn I, Kim HS, Kim SC.

Biochim Biophys Acta. 1998 Jul 1;1407(1):31-9.

38.

Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli.

Lee JH, Minn I, Park CB, Kim SC.

Protein Expr Purif. 1998 Feb;12(1):53-60.

PMID:
9473457

Supplemental Content

Support Center